๐
Ngenla
somatrogon
Growth and Development
โ
Authorised
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/ngenla